ESC Premium Access

Guidelines: commonalities and discrepancies.

logo

Topic: Lipids
Sponsored by Sanofi and Regeneron

Congress Presentation

About the speaker

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

6 more presentations in this session

Introduction - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor C. Cannon (Boston, US)

Thumbnail

LDL-C exposure and atherosclerosis progression.

Speaker: Professor A. Catapano (Milan, IT)

Thumbnail

PCSK9 inhibition: the data today and tomorrow.

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Learnings and clinical insights from SPIRE.

Speaker: Doctor P. Ridker (Boston, US)

Thumbnail

Identifying appropriate patients to treat: a case-based approach.

Speaker: Professor C. Cannon (Boston, US) Professor A. Catapano (Milan, IT) Professor S. Nicholls (Melbourne, AU) Doctor P. Ridker (Boston, US) Doctor J. Robinson (Iowa, US)

Thumbnail

Access the full session

PSCK9 inhibition: a new horizon in LDL-C management

Speakers: Doctor J. Robinson, Professor C. Cannon, Professor A. Catapano, Professor S. Nicholls, Doctor P. Ridker...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk